Dextrose 50% (Glucose 50%)
Brand names: Glucose 50% Injection
Dextrose 50% is a concentrated intravenous glucose solution used in the emergency treatment of severe symptomatic hypoglycaemia.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It rapidly raises blood glucose by providing a directly usable carbohydrate substrate to the circulation and central nervous system.
Prescribing in practice
- Highly hypertonic and irritant — give into a large or central vein and confirm patency, as extravasation can cause severe tissue necrosis.
- Check capillary or laboratory glucose before and after administration and identify the cause of hypoglycaemia.
- Use cautiously in suspected thiamine deficiency, where thiamine should be considered alongside or before glucose to reduce the risk of precipitating Wernicke's encephalopathy.
Monitoring
Monitor blood glucose closely after administration and recheck regularly until levels are stable.
Counselling the patient
- Explain that this rapidly corrects a dangerously low blood sugar.
- Advise the patient to eat a longer-acting carbohydrate once alert to prevent recurrence.
- Tell the team to watch the cannula site for pain, swelling or leakage.
Evidence & guidelines
Intravenous glucose is the standard parenteral treatment for severe hypoglycaemia in patients unable to take oral carbohydrate.
Reference: JBDS Inpatient Hypoglycaemia Guidelines 2023; NICE CG100; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- HbA1c Converter · Diabetes
- Glucose Infusion Rate (GIR) Calculator · Glucose Management
- C-Peptide to Glucose Ratio · Diabetes Classification
- Hypoglycaemia Severity Classification · Diabetes Management
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- Neonatal Hypoglycaemia Risk Assessment · Neonatal Metabolic
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Dextrose 50% (Glucose 50%) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.